Tapio Nousiainen
Kuopio, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group.
Journal: European journal of haematology
Published: February 27, 2022
Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34+ cells in non-Hodgkin lymphoma patients.
Journal: Transfusion
Published: June 01, 2018
Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients.
Journal: Infectious diseases (London, England)
Published: January 06, 2018
Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol - a prospective nationwide study.
Journal: Infectious diseases (London, England)
Published: July 08, 2017
Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly.
Journal: Annals of hematology
Published: June 20, 2017
Old enemies in new disguises: emergence of Enterococcus faecium as a significant clinical problem at an adult haematology ward.
Journal: Infectious diseases (London, England)
Published: March 10, 2017
Pre-emptive plerixafor injection in lymphoma patients mobilized with chemotherapy plus pegfilgrastim followed by apheresis on the same day.
Journal: Journal of clinical apheresis
Published: September 09, 2016
Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL).
Journal: Journal of neuro-oncology
Published: May 05, 2016
Early immune recovery after autologous transplantation in non-Hodgkin lymphoma patients: predictive factors and clinical significance.
Journal: Leukemia & lymphoma
Published: January 15, 2016
Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: March 12, 2015
Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison.
Journal: Transfusion
Published: February 19, 2015
Light scattering by the Martian dust analog, palagonite, modeled with ellipsoids.
Journal: Optics express
Published: August 14, 2013
Last Updated: 09/26/2026